Abstract
New-generation thin strut bioabsorbable polymer drug-eluting stents (DES) have shown promising mid-term results in clinical trials and real-world registries. We sought to assess 1-year efficacy and safety outcomes in all-comer patients treated with the SYNERGY stent at our institution. All
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have